Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,367 | -18,582 | -21,479 | -26,353 | -43,270 |
| Depreciation Amortization | 15,481 | 567 | 783 | 692 | 887 |
| Income taxes - deferred | -5,280 | N/A | -1,803 | N/A | N/A |
| Accounts receivable | -316 | 106 | -446 | 50,314 | -857 |
| Other Working Capital | -4,110 | -8,766 | -10,804 | 18,704 | 21,096 |
| Other Operating Activity | 38,673 | 3,583 | 5,183 | -42,298 | -1,417 |
| Operating Cash Flow | $-18,919 | $-23,092 | $-28,566 | $1,059 | $-23,561 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 18 | 196 | N/A | N/A |
| PPE Investments | -522 | -565 | -674 | -413 | -340 |
| Purchase Of Investment | -14,935 | -8,761 | -16,403 | -53,412 | N/A |
| Sale Of Investment | 2,000 | 7,000 | 63,330 | 7,666 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 10,085 |
| Investing Cash Flow | $-13,457 | $-2,308 | $46,449 | $-46,159 | $9,745 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -59 | -54 | -54 | -32 | -20 |
| Common Stock Issued | 27,709 | 36,105 | 6,514 | 1,787 | 38,105 |
| Common Stock Repurchased | -16 | -23 | -37 | -17 | -54 |
| Other Financing Activity | -684 | -171 | 0 | -106 | -1,101 |
| Financing Cash Flow | $26,950 | $35,857 | $6,423 | $1,632 | $36,930 |
| Exchange Rate Effect | 396 | -95 | -250 | -873 | -20 |
| Beginning Cash Position | 46,354 | 35,992 | 11,936 | 56,277 | 33,183 |
| End Cash Position | 41,324 | 46,354 | 35,992 | 11,936 | 56,277 |
| Net Cash Flow | $-5,030 | $10,362 | $24,056 | $-44,341 | $23,094 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,919 | -23,092 | -28,566 | 1,059 | -23,561 |
| Capital Expenditure | -522 | -565 | -674 | -413 | -340 |
| Free Cash Flow | -19,441 | -23,657 | -29,240 | 646 | -23,901 |